In this study, the role of AURKA gene expression with clinicopathological details was investigated using in silico and molecular docking study and proposed that the expression of AURKA gene may be regulated by miR-32-3p through RNA induced silencing complex in BC. The gene discussed is AURKA; the disease is breast cancer.